Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Money on the Move

Proscia
By Author Proscia | June 15, 2022

With the funding, Proscia will focus on precision medicine with AI-enabled pathology. The company also hopes the money will help to expand its sales, marketing and support teams, as well as grow more distribution partnerships following its recent OEM agreement with Siemens Healthineers.

Our website uses cookies. By using this site, you agree to its use of cookies.